Disclosure of changes in interest in shareholding Afrocentric Investment Corporation Limited (Incorporated in the Republic of South Africa) (Registration number: 1988/000570/06) JSE Code: ACT ISIN: ZAE000078416 (“AfroCentric” or “the Company”) DISCLOSURE OF CHANGES IN INTEREST IN SHAREHOLDING In accordance with section 122(3)(b) of the Companies Act, Act 71 of 2008, as amended, and paragraph 3.83(b) of the JSE Limited Listings Requirements, shareholders are advised that AfroCentric has been notified of the following changes in shareholding: • During June 2017 Daniel Janse Van Vuuren] (“Dannie”) disposed of his 5.83% indirect beneficial interest in the securities of the Company to ARC Health (Pty) Limited (“ARC”), following which, Dannie now holds a 0% indirect interest in the total issued share capital of the Company • During June 2017, ARC, through its wholly owned subsidiary ARC Health Investment Proprietary Limited acquired the indirect beneficial interest in the securities of the Company from Dannie, following which ARC held a 14.14% interest in the Company, being an 8.80% direct beneficial interest and a 5.34% indirect beneficial interest in the securities of the Company. • During December 2018 ARC disposed of its indirect beneficial interest in the securities of the Company Royal Queens Holdings Proprietary Limited (“Royal Queens”) (“Disposal”). Following the Disposal ARC now holds an 8.80% direct beneficial interest and a 0% indirect interest in the securities of the Company. • During December 2018 Royal Queens acquired an indirect beneficial interest in the securities of the Company from ARC, following which, Royal Queens now holds a 5.71% interest in the Company being a direct beneficial interest of 5.34% and 0.37% indirect beneficial interest in the securities of the Company. Johannesburg 26 February 2019 Sponsor Sasfin Capital (a member of the Sasfin Group) Date: 26/02/2019 04:02:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.